Patent · US Active

Inhibitors of the interaction between MDM2 and p53

US7834016B2 · kind B2 · utility

4Cited by
5References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2005
Grant dateNov 16, 2010
Priority date—
Expiry dateJul 20, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I)wherein n, m, p, s, t, R1, R2, R3, R4, R5, R6, R7, X, Y, Q and Z have defined meanings.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.